Coegin Pharma AB reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was SEK 1.7 million compared to SEK 0.443 million a year ago. Net loss was SEK 12.8 million compared to SEK 6.18 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.01 a year ago. Diluted loss per share from continuing operations was SEK 0.02 compared to SEK 0.01 a year ago.
For the six months, revenue was SEK 2.82 million compared to SEK 0.459 million a year ago. Net loss was SEK 19.29 million compared to SEK 15.85 million a year ago. Basic loss per share from continuing operations was SEK 0.03 compared to SEK 0.03 a year ago. Diluted loss per share from continuing operations was SEK 0.03 compared to SEK 0.03 a year ago.